Acid Ceramidase as a Chemotherapeutic Target to Overcome Resistance to the Antitumoral Effect of Choline Kinase Inhibition

MLA

Ramirez de Molina, A., et al. “Acid Ceramidase as a Chemotherapeutic Target to Overcome Resistance to the Antitumoral Effect of Choline Kinase Inhibition.” Current Cancer Drug Targets, vol. 12, no. 6, July 2012, pp. 617–24. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs27909551&authtype=sso&custid=ns315887.

APA

Ramirez de Molina, A., de la Cueva, A., Machado-Pinilla, R., Rodriguez-Fanjul, V., Gomez del Pulgar, T., Cebrian, A., Perona, R., & C. Lacal, J. (2012). Acid Ceramidase as a Chemotherapeutic Target to Overcome Resistance to the Antitumoral Effect of Choline Kinase Inhibition. Current Cancer Drug Targets, 12(6), 617–624.

Chicago

Ramirez de Molina, A., A. de la Cueva, R. Machado-Pinilla, V. Rodriguez-Fanjul, T. Gomez del Pulgar, A. Cebrian, R. Perona, and J. C. Lacal. 2012. “Acid Ceramidase as a Chemotherapeutic Target to Overcome Resistance to the Antitumoral Effect of Choline Kinase Inhibition.” Current Cancer Drug Targets 12 (6): 617–24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs27909551&authtype=sso&custid=ns315887.